Alexander Knuth, M.D.

Alexander Knuth, M.D. is Professor emeritus of the University of Zurich, Switzerland. Dr. Knuth’s pioneering work in cancer immunology led to the discovery of multiple human cancer antigens including MAGE, the first of the so-called cancer/testis (CT) family of antigens. CT antigens, including MAGE and NY-ESO-1, were found to be promising targets for the development of cancer vaccines and vaccination strategies. He played a pivotal role in the early development of peptide-based vaccines and adjuvants, established immune-monitoring techniques, and discovered several tumor immune-escape mechanisms. He has received multiple prizes and  awards, including the prestigious Johann-Georg-Zimmermann Medal. Dr. Knuth is a member of the Cancer Research Institute’s (CRI) Scientific Advisory Council and of CRI’s global clinical investigator network.